IL75120A - 2-substituted-6-,7-dihydro-3h,5h-pyrrolo(2,3-f)benzimidazole-6-(thi)ones,processes for the preparation thereof and pharmaceutical compositions containing them - Google Patents

2-substituted-6-,7-dihydro-3h,5h-pyrrolo(2,3-f)benzimidazole-6-(thi)ones,processes for the preparation thereof and pharmaceutical compositions containing them

Info

Publication number
IL75120A
IL75120A IL75120A IL7512085A IL75120A IL 75120 A IL75120 A IL 75120A IL 75120 A IL75120 A IL 75120A IL 7512085 A IL7512085 A IL 7512085A IL 75120 A IL75120 A IL 75120A
Authority
IL
Israel
Prior art keywords
thi
pyrrolo
benzimidazole
dihydro
ones
Prior art date
Application number
IL75120A
Other languages
English (en)
Other versions
IL75120A0 (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843417643 external-priority patent/DE3417643A1/de
Priority claimed from DE19843446417 external-priority patent/DE3446417A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Priority to IL84769A priority Critical patent/IL84769A/xx
Publication of IL75120A0 publication Critical patent/IL75120A0/xx
Priority to IL84769A priority patent/IL84769A0/xx
Publication of IL75120A publication Critical patent/IL75120A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/96Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL75120A 1984-05-12 1985-05-07 2-substituted-6-,7-dihydro-3h,5h-pyrrolo(2,3-f)benzimidazole-6-(thi)ones,processes for the preparation thereof and pharmaceutical compositions containing them IL75120A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL84769A IL84769A (en) 1984-05-12 1985-05-07 Substituted indolin-2-(thi)ones
IL84769A IL84769A0 (en) 1984-05-12 1987-12-09 Substituted indolin-2-(thi)ones

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843417643 DE3417643A1 (de) 1984-05-12 1984-05-12 Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE19843446417 DE3446417A1 (de) 1984-12-20 1984-12-20 Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte

Publications (2)

Publication Number Publication Date
IL75120A0 IL75120A0 (en) 1985-09-29
IL75120A true IL75120A (en) 1989-02-28

Family

ID=25821132

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75120A IL75120A (en) 1984-05-12 1985-05-07 2-substituted-6-,7-dihydro-3h,5h-pyrrolo(2,3-f)benzimidazole-6-(thi)ones,processes for the preparation thereof and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (2) US4666923A (ja)
EP (1) EP0161632B1 (ja)
JP (2) JPH0647593B2 (ja)
KR (1) KR870001201B1 (ja)
AU (1) AU560349B2 (ja)
DE (1) DE3582447D1 (ja)
DK (1) DK209585A (ja)
ES (1) ES542976A0 (ja)
FI (1) FI81351C (ja)
GR (1) GR851085B (ja)
HU (1) HU193754B (ja)
IL (1) IL75120A (ja)
NO (1) NO851862L (ja)
NZ (1) NZ212005A (ja)
PH (1) PH22863A (ja)
PL (2) PL147842B1 (ja)
PT (1) PT80425B (ja)
SU (1) SU1480770A3 (ja)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL147842B1 (en) * 1984-05-12 1989-08-31 Method of obtaining novel pyroisobenzimidazoles
DE3445669A1 (de) * 1984-12-14 1986-06-19 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3524067A1 (de) * 1985-07-05 1987-01-08 Boehringer Mannheim Gmbh Neue benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3530825A1 (de) * 1985-08-29 1987-03-05 Boehringer Mannheim Gmbh Neue benzodipyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3531678A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3626664A1 (de) * 1986-08-07 1988-02-11 Boehringer Mannheim Gmbh Tricyclische benzotriazole, verfahren zu ihrer herstellung sowie arzneimittel
DE3639466A1 (de) * 1986-11-18 1988-05-19 Thomae Gmbh Dr K Neue pyrrolo-benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3642315A1 (de) * 1986-12-11 1988-06-23 Boehringer Mannheim Gmbh Neue pyrrolobenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
DE3740985A1 (de) * 1987-12-03 1989-06-15 Boehringer Mannheim Gmbh Verwendung linear anellierter tricyclen als hemmer der erythrozytenaggregation
US4963677A (en) * 1987-12-30 1990-10-16 Orion Corporation Ltd. Heterocyclic lactam compounds
DE3855327D1 (de) * 1987-12-30 1996-07-04 Orion Yhtymae Oy Heterocyclische Verbindungen
DE3803775A1 (de) * 1988-02-09 1989-08-17 Boehringer Mannheim Gmbh Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US5324911A (en) * 1990-01-08 1994-06-28 Schroer Manufacturing Company Heated animal surgery table
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20060142247A1 (en) * 2004-12-17 2006-06-29 Guy Georges Tricyclic heterocycles
CN101160312A (zh) * 2005-04-14 2008-04-09 霍夫曼-拉罗奇有限公司 三环吡咯衍生物、它们的制备和作为药剂的应用
WO2006108489A1 (en) * 2005-04-14 2006-10-19 F. Hoffmann-La Roche Ag Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
AU2006326247A1 (en) * 2005-12-15 2007-06-21 F. Hoffmann-La Roche Ag Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
CN101400681A (zh) * 2006-03-23 2009-04-01 霍夫曼-拉罗奇有限公司 取代的吲唑衍生物,它们的制备和作为药剂的应用
US8063225B2 (en) * 2006-08-14 2011-11-22 Chembridge Corporation Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
RU2443704C1 (ru) * 2010-10-29 2012-02-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СУЛЬФАТЫ 2-АРИЛ-4-ДИАЛКИЛАМИНОЭТИЛ-3-ФЕНИЛПИРРОЛО[1,2-a]-БЕНЗИМИДАЗОЛОВ, ОБЛАДАЮЩИЕ АНТИОКСИДАНТНЫМИ И АНТИРАДИКАЛЬНЫМИ СВОЙСТВАМИ
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
JP6116693B2 (ja) 2012-09-13 2017-04-19 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Cns障害の処置のための2−オキソ−2,3−ジヒドロ−インドール
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス,インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
GB201709456D0 (en) * 2017-06-14 2017-07-26 Ucb Biopharma Sprl Therapeutic agents
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
JP6854953B1 (ja) 2020-06-16 2021-04-07 株式会社ソディック ワイヤ放電加工装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1158532A (en) * 1967-01-05 1969-07-16 Centre Nat Rech Scient 2-Oxoindoline-3-Carboxylic Acids and Esters thereof
BE714717A (ja) * 1967-05-12 1968-09-30
FR1529901A (fr) * 1967-05-12 1968-06-21 Centre Nat Rech Scient Procédé de préparation de lactames se rattachant à l'indolinone et à l'oxo quinoléine
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
PL147842B1 (en) * 1984-05-12 1989-08-31 Method of obtaining novel pyroisobenzimidazoles

Also Published As

Publication number Publication date
ES8603178A1 (es) 1986-01-01
JPH0741474A (ja) 1995-02-10
IL75120A0 (en) 1985-09-29
JPH0647593B2 (ja) 1994-06-22
FI81351C (fi) 1990-10-10
US4666923A (en) 1987-05-19
EP0161632A2 (de) 1985-11-21
AU4222285A (en) 1985-11-14
AU560349B2 (en) 1987-04-02
EP0161632B1 (de) 1991-04-10
PT80425A (de) 1985-06-01
JPH0772185B2 (ja) 1995-08-02
KR850008170A (ko) 1985-12-13
FI81351B (fi) 1990-06-29
PT80425B (de) 1987-04-16
PH22863A (en) 1989-01-19
US4963686A (en) 1990-10-16
GR851085B (ja) 1985-11-25
PL253246A1 (en) 1986-08-26
SU1480770A3 (ru) 1989-05-15
EP0161632A3 (en) 1986-06-11
JPS60246386A (ja) 1985-12-06
FI851869L (fi) 1985-11-13
DK209585A (da) 1985-11-13
HU193754B (en) 1987-11-30
KR870001201B1 (ko) 1987-06-20
FI851869A0 (fi) 1985-05-10
PL144822B1 (en) 1988-07-30
DK209585D0 (da) 1985-05-10
HUT37938A (en) 1986-03-28
NO851862L (no) 1985-11-13
ES542976A0 (es) 1986-01-01
PL147842B1 (en) 1989-08-31
NZ212005A (en) 1989-07-27
DE3582447D1 (de) 1991-05-16

Similar Documents

Publication Publication Date Title
IL75120A (en) 2-substituted-6-,7-dihydro-3h,5h-pyrrolo(2,3-f)benzimidazole-6-(thi)ones,processes for the preparation thereof and pharmaceutical compositions containing them
IL75400A0 (en) Dialkoxypyridines,processes for the preparation thereof and pharmaceutical compositions containing the same
IL76591A0 (en) Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
GB8613688D0 (en) Pharmaceutical composition
ZA859756B (en) Peptide-aldehydes,process for the preparation thereof and pharmaceutical compositions containing the same
GB8708659D0 (en) Pharmaceutical composition
GB2153678B (en) Pharmaceutical composition
EP0163178A3 (en) Pharmaceutical composition
ZA879166B (en) Pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
EG17710A (en) Process for the preparation isosilybin-free silbinin and pharmaceutical compositions containing them
GB2153677B (en) Pharmaceutical composition
IL78576A0 (en) 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same
GB8713632D0 (en) Oculistics pharmaceutical composition
GB8628373D0 (en) Pharmaceutical composition
GB8709166D0 (en) Pharmaceutical composition
GB8614189D0 (en) Pharmaceutical composition
ZA853375B (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
GB2153676B (en) Pharmaceutical composition
GB8621008D0 (en) Pharmaceutical composition
GB8706824D0 (en) Pharmaceutical composition
GB8722205D0 (en) Pharmaceutical composition
GB8704660D0 (en) Pharmaceutical composition
GB8725539D0 (en) Pharmaceutical composition
ZA876263B (en) Pharmaceutical composition
ZA876748B (en) Pharmaceutical composition